Morgan Stanley Call 260 AMG 17.01.../ DE000MB1WVS2 /
1/10/2025 9:59:43 AM | Chg.-0.020 | Bid11:35:55 AM | Ask11:35:55 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.610EUR | -3.17% | 0.640 Bid Size: 5,000 |
0.750 Ask Size: 5,000 |
AMGEN INC. DL-... | 260.00 - | 1/17/2025 | Call |
GlobeNewswire
8/29/2024
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
8/28/2024
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
8/15/2024
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
8/12/2024
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
8/8/2024
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
8/8/2024
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
8/5/2024
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
8/1/2024
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024